Another advantage of hormone-induced rat mammary tumor models concerns the possibility of impelling tumor growth regression via hormone administration cessation or in the presence of selective ER modulator drugs, such as tamoxifen [137, 212, 217]. This evidence concerns the gene ESR1 and breast cancer.